| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.35 | 0.08 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.08 |